MACASHHMinisterial Advisory Committee on AIDS, Sexual Health and Hepatitis (Australia)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Despite changes in eligibility criteria (Hellard, Sacks-Davis, & Gold, 2009; MACASHH, 2006) and efforts to raise awareness of the availability of treatment, uptake of treatment by this group remains low (NCHECR, 2010), as is the case elsewhere in the world (Grebely et al., 2008; Hellard et al., 2009; Mehta et al., 2008).
Sharing needles and syringes and other equipment for injecting drugs is the primary route of transmission for hepatitis C virus (HCV) in Australia (Crofts, Jolley, Kaldor, van Beek, & Wodak, 1997; MACASHH, 2006).
To date, the quantitative research examining HCV risk perceptions is limited, particularly in an Australian context where HCV is the prominent blood-borne virus among PWID (MACASHH, 2006).